Direct Oral Anticoagulants: Overcoming the Challenges of Managing Venous Thromboembolism in Children - 21/12/21
Doi : 10.1016/j.jpeds.2021.09.025
Christoph Male, MD 1, ⁎ 
, Paul Monagle, MD 2, 3, Manuela Albisetti, MD 4, Leonardo R. Brandão, MD 5, 6, Guy Young, MD 7
, Paul Monagle, MD 2, 3, Manuela Albisetti, MD 4, Leonardo R. Brandão, MD 5, 6, Guy Young, MD 7 1 Department of Pediatrics, Medical University of Vienna, Vienna, Austria
2 Royal Children's Hospital, Murdoch Children's Research Institute, University of Melbourne, Melbourne, Australia
3 Australia and Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia
4 Division of Hematology, University Children's Hospital of Zurich, Zurich, Switzerland
5 The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
6 Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
7 Children's Hospital Los Angeles, University of Southern California, Keck School of Medicine, Los Angeles, CA
∗Reprint requests: Christoph Male, MD, Department of Pediatrics, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, AustriaDepartment of PediatricsMedical University of ViennaWaehringer Guertel 18-20Vienna1090Austria
Keywords : anticoagulants, pediatrics, risk factors, thrombosis
Abbreviations : CVC, DOAC, DVT, eGFR, GI, LMWH, PD, PK, UFH, VKA, VTE
Plan
| The authors have conducted reviews and provided input on each draft. C.M. has received personal fees from Bayer AG, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, and Pfizer, and fees paid to his institution from Bayer, Boehringer Ingelheim, Bristol Myers Squibb, and Pfizer. G.Y. has received honoraria and consulting payments from Bayer and Daiichi Sankyo. M.A. is a member of a pediatric expert working group for Boehringer Ingelheim and participated in advisory board activities of Daiichi Sankyo. L.B. has received consulting payments from Boehringer Ingelheim. P.M. declares no financial conflicts of interest. |
© 2021
Publié par Elsevier Masson SAS.
Vol 240
P. 14-23 - janvier 2022 Retour au numéro
Article précédent
- Going Home with a Patent Ductus Arteriosus: Is it Benign?
- Adrianne Rahde Bischoff, Stephania Cavallaro Moronta, Patrick J. McNamara
- Risk of Extreme, Moderate, and Late Preterm Birth by Maternal Race, Ethnicity, and Nativity
- Teniola I. Egbe, Diana Montoya-Williams, Kate Wallis, Molly Passarella, Scott A. Lorch
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?